Drug Profile
Vandortuzumab vedotin
Alternative Names: Anti-STEAP1-vc-MMAE; DSTP-3086S; RG-7450Latest Information Update: 18 Dec 2023
Price :
$50
*
At a glance
- Originator Genentech
- Class Antineoplastics; Auristatins; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants; Mitosis inhibitors; STEAP1 protein inhibitors; Tubulin inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Prostate cancer